Thalidomide

teratogen - causes significant, often fatal birth defects if administered even only once during pregnancy. Removed from the market across europe in 1961, never entered the US market. Now used as a treatment for some cancers and other illnesses, with appropriate safeguards.

References

Metadata

Created: 2026-01-23

Last Updated: 2026-01-23